Inspection Record

10445517 Canada Inc / North Pharmaceuticals / DAC Pharmaceuticals — Health Canada Inspection Findings

Health CanadaInspected 2025-03-13 3 findingsOther quality systemEquipment and facilityQuality unit oversight

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The assessment to release finished products was inadequate.

2Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

3Quality unit oversight

The quality control department did not evaluate the results of the annual product quality review.

About this record

Extracted automatically from the document of the Health Canada inspection on 2025-03-13. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

2023-03-22 · Health Canada · 5 findings
10445517 Canada Inc / North Pharmaceuticals / DAC Pharmaceuticals findings history — including this company's other documents Health Canada documents, 2025 Go to Findings search